Trajan Group Holdings Ltd
ASX:TRJ
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
T
|
Trajan Group Holdings Ltd
ASX:TRJ
|
AU |
|
Pancontinental Energy NL
ASX:PCL
|
AU |
|
Digital Currency X Technology Inc
NASDAQ:DCX
|
CN |
|
Yue Yuen Industrial (Holdings) Ltd
HKEX:551
|
HK |
|
Mohawk Industries Inc
NYSE:MHK
|
US |
|
C
|
Cashbuild Ltd
JSE:CSB
|
ZA |
|
Y
|
YC Corp
KOSDAQ:232140
|
KR |
|
C
|
Choong Ang Vaccine Laboratory
KOSDAQ:072020
|
KR |
Trajan Group Holdings Ltd
Trajan Group Holdings Ltd. engages in the designing, manufacturing and supply of products and solutions that enhance scientific measurement. The firm is developing and manufacturing analytical science instruments, devices and solutions used in the analysis of biological, food and environmental samples. The firm is focused on serving life science, biopharmaceutical, and analytical companies in the United States, Australia, Europe, and Asia. The firm is operating in two segments, which includes Analytical Products and Life Science Solutions. Its Analytical Products include Metal syringes, Gas tight syringes, eVol, liquid extraction (uLLE), Electrokinetic extraction (EkE), Ferrules, Microfluidics, Emitter tips, Septa and caps and Porous polymer monoliths. Its Life Science Solutions include Dispensing syringes, Microscope slides, Coverslips, Slide and cassette storage, Liquid powder dispensing, Infusion automation, hemaPEN, Microbiopsy and Hummingbird. The company also offers micro-biopsy device for skin sampling, including Mitra device.
Trajan Group Holdings Ltd. engages in the designing, manufacturing and supply of products and solutions that enhance scientific measurement. The firm is developing and manufacturing analytical science instruments, devices and solutions used in the analysis of biological, food and environmental samples. The firm is focused on serving life science, biopharmaceutical, and analytical companies in the United States, Australia, Europe, and Asia. The firm is operating in two segments, which includes Analytical Products and Life Science Solutions. Its Analytical Products include Metal syringes, Gas tight syringes, eVol, liquid extraction (uLLE), Electrokinetic extraction (EkE), Ferrules, Microfluidics, Emitter tips, Septa and caps and Porous polymer monoliths. Its Life Science Solutions include Dispensing syringes, Microscope slides, Coverslips, Slide and cassette storage, Liquid powder dispensing, Infusion automation, hemaPEN, Microbiopsy and Hummingbird. The company also offers micro-biopsy device for skin sampling, including Mitra device.
Guidance Reaffirmed: Management reconfirmed full-year FY '26 revenue guidance of more than $170 million and normalized EBITDA of more than $16 million, despite a challenging Q1.
Record Q2 Performance: Q2 was a record quarter with over $45 million in revenue, building momentum for the second half of the year.
Challenging Q1: Q1 results were pressured by lower capital equipment orders, tariff timing, and deliberate investments in inventory and regional capabilities.
Cost Reduction Initiatives: Project Neptune cost savings are expected to accelerate in H2, with much of the groundwork completed by year-end.
Macroeconomic Volatility: Management noted ongoing risks from currency swings, tariffs, and geopolitical events, but remains confident in achieving guidance barring unforeseen disruptions.
